4.The authorized considerations on the pre-clinical study of drug-eluting coronary stent system.
Maobo CHENG ; Xinli SHI ; Jianxiong JIA ; Jingjing MIAO ; Wei LIU ; Feilong NIE
Chinese Journal of Medical Instrumentation 2014;38(6):461-462
China Food and Drug Administration didn't issue any guideline on the pre-clinical study of drug-eluting coronary stent system, the basic requirement of the authorized administration was summarized to help manufacture prepare the document during the registration process.
China
;
Drug Evaluation, Preclinical
;
methods
;
Drug-Eluting Stents
;
Guidelines as Topic
5.Response Evaluation of Chemotherapy for Lung Cancer.
Tuberculosis and Respiratory Diseases 2017;80(2):136-142
Assessing response to therapy allows for prospective end point evaluation in clinical trials and serves as a guide to clinicians for making decisions. Recent prospective and randomized trials suggest the development of imaging techniques and introduction of new anti-cancer drugs. However, the revision of methods, or proposal of new methods to evaluate chemotherapeutic response, is not enough. This paper discusses the characteristics of the Response Evaluation Criteria In Solid Tumor (RECIST) version 1.1 suggested in 2009 and used widely by experts. It also contains information about possible dilemmas arising from the application of response assessment by the latest version of the response evaluation method, or recently introduced chemotherapeutic agents. Further data reveals the problems and limitations caused by applying the existing RECIST criteria to anti-cancer immune therapy, and the application of a new technique, immune related response criteria, for the response assessment of immune therapy. Lastly, the paper includes a newly developing response evaluation method and suggests its developmental direction.
Drug Therapy*
;
Evaluation Studies as Topic
;
Lung Neoplasms*
;
Lung*
;
Methods
;
Prospective Studies
;
Response Evaluation Criteria in Solid Tumors
6.Opportunity and challenge of post-marketing evaluation of traditional Chinese medicine.
Xiao-Xi DU ; Hai-Bo SONG ; Jing-Tian REN ; Le YANG ; Xiao-Xin GUO ; Yu PANG
China Journal of Chinese Materia Medica 2014;39(18):3427-3429
Post-marketing evaluation is a process which evaluate the risks and benefits of drug clinical application comprehensively and systematically, scientific and systematic results of post-marketing evaluation not only can provide data support for clinical application of traditional Chinese medicine, but also can be a reliable basis for the supervision department to develop risk control measures. With the increasing demands for treatment and prevention of disease, traditional Chinese medicine has been widely used, and security issues are also exposed. How to find risk signal of traditional Chinese medicine in the early stages, carry out targeted evaluation work and control risk timely have become challenges in the development of traditional Chinese medicine industry.
Drug Evaluation
;
methods
;
Drugs, Chinese Herbal
;
Humans
;
Medicine, Chinese Traditional
10.Strategy of molecular drug design: hits, leads and drug candidates.
Acta Pharmaceutica Sinica 2008;43(9):898-904
Hits, leads and drug candidates constitute three millstones in the course of drug discovery and development. The definition of drug candidates is a critical point in the value chain of drug innovation, which not only differentiates the research and development stages, but more importantly, determines the perspective and destiny of the pre-clinical and clinical studies. All outcomes from the development stage are actually attributed to the chemical structure of candidates. The quality of candidates, however, is restricted by the drug-likeness of lead compounds, which in turn is decided by the characteristics of hits. The hit-to-lead is to provide a promising and druggable structure for further development, whereas the optimization of lead compounds is a process to transform an active compound into a drug, which in essence is molecular manipulation in multi-dimensional space related to pharmacodynamic, pharmacokinetic, physico-chemical, and safety properties. This review discusses the strategic principles in hit discovery, lead identification and optimization, as well as drug candidate definition with practical examples.
Animals
;
Drug Design
;
Drug Evaluation, Preclinical
;
methods
;
Drug Industry
;
methods
;
Humans
;
Molecular Structure
;
Pharmaceutical Preparations
;
chemistry